Cart
sales@molnova.com
DPC-681
CAS No. 284661-68-3
DPC-681( DPH-153893 )
Catalog No. M13867 CAS No. 284661-68-3
A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 514 | Get Quote |
|
| 50MG | 1962 | Get Quote |
|
| 100MG | 2520 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDPC-681
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM.
-
DescriptionA potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM; showes no loss in potency towardrecombinant mutant HIVs with the D30N mutation and a fivefold or smaller loss in potency toward mutant variants with three to five amino acid substitutions.
-
In Vitro——
-
In Vivo——
-
SynonymsDPH-153893
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number284661-68-3
-
Formula Weight669.8495
-
Molecular FormulaC35H48FN5O5S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)[C@@H](C(N)=O)N(C(CNCC1=CC=CC(F)=C1)=O)[C@@H](CC2=CC=CC=C2)[C@H](O)CN(S(=O)(C3=CC=CC(N)=C3)=O)CC(C)C
-
Chemical NameL-Valinamide, N-[(3-fluorophenyl)methyl]glycyl-N-[(1S,2R)-3-[[(3-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kaltenbach RF 3rd, et al. Antimicrob Agents Chemother. 2001 Nov;45(11):3021-8.
2. Solon EG, et al. Drug Metab Dispos. 2002 Nov;30(11):1164-9.
molnova catalog
related products
-
YIR-819 TFA salt
YIR-819 is a small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 2.6 uM against YTA48P virus with no significant cytotoxicity (CC50=33 uM).
-
HIV p17 Gag 77-85
HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.
-
MK-2048
MK-2048 is a potent inhibitor of HIV-1 integrase (IN) and IN mutant R263K with IC50 of 2.6 nM and 1.5 nM, respectively.
